Precision Prostate Cancer Diagnostic Testing
29 November 2023 2025-03-18 22:28Precision Prostate Cancer Diagnostic Testing
Precision Prostate Cancer Diagnostic Testing
Our Approach to Precision Prostate Cancer Diagnostics
Prostate cancer is the most common cancer among Canadian men. We understand a suspicion or diagnosis of prostate cancer will result in anxiety and uncertainty for both patients and their families. New research advances have rapidly transformed diagnostic non-invasive tools available to Canadians for prostate cancer. Our specialists aim to provide you with up-to-date precision diagnostics to help enable “smarter” testing and the clarity needed to take life-changing action.
What We Offer You With Precision Prostate Cancer Diagnostics?
Advanced precision testing
On-site phlebotomy
Multi-disciplinary treatment
What Is Prostate Cancer Precision Diagnostics?
Prostate Cancer Precision Diagnostics Overview
1 in 8 men will develop prostate cancer in their lifetime
Diagnostic testing is rapidly advancing, with non-invasive tools that provide valuable actionable insights that will inform your prostate cancer journey and treatment.
13% of patients with prostate cancer have an inherited genetic change that increases their risk of developing certain cancers.
With more critical information provided, we want to help you feel confident about your next step, whether to understand your cancer risk, to confirm a diagnosis of prostate cancer, or plan for your best personalized treatment plan。
Conditions Treated Prostate Cancer
Learn more about prostate cancer Here.
Precision Prostate Cancer Diagnostic Tests Offered:
Biomarker Testing (Select MDx)
A biomarker is a biological molecule found in our bodies that can tell us if something is normal or not. Biomarkers have become part of the molecular tests we use to determine your risk of aggressive prostate cancer, and if you are at high risk you may benefit from a prostate biopsy and further testing to allow for early detection and treatment.
Prostate biomarker testing may be ordered if you have:
- Elevated PSA level
- Abnormal physical exam findings
- A family history of prostate cancer
- Other factors that may put you at elevated risk such as age or ethnic background
Select MDx
Select MDx is a urine-based test
- All you need to do is provide a urine specimen during a visit to your urologist’s office.
- The specimen will be sent to Mdxhealth for Select mdx for Prostate Cancer testing.
- Your Select mdx test results will be sent to your urologist within 5 days.
Action You Can Initiate and Knowledge You Can Use:
If you learn that your PSA level is abnormal and/or that you have other clinical risk factors (age, increased prostate volume, family history of prostate cancer, abnormal DRE result) for prostate cancer, talk to your urologist about ordering the Select mdx test—before having a prostate biopsy.
Select MDx will give you and your urologist additional prostate cancer-specific information to help determine if you should have a prostate biopsy.
This is a private pay test. Please check your insurance plan for coverage.
Learn more about Select MDx Here.
Confirm MDx
Research has shown that up to 30% of men with a negative/benign prostate biopsy result actually do have prostate cancer.
The Confirm mdx test examines your negative biopsy tissue at the DNA level to help identify undetected cancers that may be present anywhere in your prostate.
How does Confirm mdx work?
Confirm mdx is Performed on the Tissue from Your Prior Biopsy.
Confirm mdx for Prostate Cancer works at the DNA level to help identify undetected cancers. The test is able to detect abnormal DNA changes associated with the presence of prostate cancer. These changes cannot be seen by the standard microscopic evaluation traditionally used by pathologists to screen prostate biopsies.
Is the Confirm mdx for you?
You are eligible to have Confirm mdx testing if you have received any of the following prostate biopsy results within a prior 30 month timeframe:
- Negative/benign
- HGPIN (high-grade prostatic intraepithelial neoplasia)
- Atypia (atypical glands suspicious for malignancy)
- ASAP (atypical small acinar proliferation)
- PIA (proliferative inflammatory atrophy, or lesion)
This is a private pay test. Please check your insurance plan for coverage.
Learn more about the GPS test Here.
Genomic Prostate Score (GPS) test
Just as every patient is different, so is every prostate cancer tumor. The Genomic Prostate Score (GPS) test uses genomics to give you and your doctor important risk information about how your individual tumor will likely behave. Valuable insights include:
- How aggressive your cancer is
- How likely you are to die from your cancer within 10 years of surgery
- How likely your cancer is to spread to other parts of your body (metastasis) within 10 years of surgery
How does the GPS test work?
The GPS test is Performed on the Tissue from Your Prior Biopsy.
The Genomic Prostate Score (GPS) test is performed on a small tissue sample that’s already been taken from your most recent biopsy. Once the sample has arrived at the mdxhealth lab, the GPS test measures the activity of the group of cancer-related genes that are in your tumor tissue.
Is the GPS test right for you?
If you are a man who has been recently diagnosed with prostate cancer and have not yet begun treatment with surgery or radiation therapy, the GPS test might be appropriate for you. The GPS test isn’t appropriate for those with advanced prostate cancer. The test can only be ordered by a licensed healthcare professional.
This is a private pay test. Please check your insurance plan for coverage.
Learn more about the GPS test Here.
4Kscore® Test
The 4Kscore® Test is an FDA approved follow-up blood test after an abnormal PSA and/or digital rectal exam (DRE) to assess the probability of finding aggressive prostate cancer if you were to have a prostate biopsy.
The test measures four prostate-specific biomarkers (Total PSA, Free PSA, Intact PSA, and human kallikrein 2 [hK2]), along with your clinical information (patient age, prior biopsy history, digital rectal exam result) using a complex algorithm to assess the probability of finding aggressive prostate cancer if you were to have a prostate biopsy.
This is a private pay test. Please check your insurance plan for coverage.
Learn more about the 4Kscore® test Here.
Resolve MDx
Get fast, directed treatment with Resolve MDx, an advanced UTI test. Resolve mdx uses PCR technology to pinpoint what is causing the infection, and it identifies personalized antibiotic options to clear it up.
Resolve MDx provides you and your doctor with:
- Results within 24-48 hours for quicker UTI relief/resolution
- Specific cause(s) of infection identified, even when more than one organism is causing the infection
- Actionable and easy to understand report allows your doctor to make informed treatment decisions
- Personalized oral antibiotic options to better address your specific infection
- Antibiotic Stewardship. Nearly 50% of prescribed patients are prescribed the wrong antibiotic
Is Resolve MDx right for you?
This UTI test has been developed especially for patients who have been suffering from recurrent, persistent, and complicated UTIs.
This is a private pay test. Please check your insurance plan for coverage.
Learn more about the Resolve MDx Here.
Genetic Testing
DNA is the unique code that holds the instructions for your body’s functions. Based on your personal and family history of cancer, you may benefit from genetic testing that studies your DNA using a saliva or blood sample. Testing looks for gene changes (variants) that are linked to certain diseases or cancer types.
Genetic testing may confirm a clinical diagnosis and guide treatment and management decisions. At-risk relatives may also be identified, allowing pursuit of a diagnostic evaluation, early detection and improved clinical outcome.
Learn more about Invitae Genetic Testing for Prostate Cancer Here.
Transperineal Prostate Biopsy
Transperineal prostate biopsy is performed in men with a suspicion of prostate cancer. This suspicion may be due to an elevated prostate specific antigen (PSA) blood test, elevated risk result on prostate cancer biomarker testing, abnormal examination, or recommendation as per prostate imaging findings.
Advantages of the transperineal biopsy approach include decreased infection rates, higher sampling accuracy, and ability to target lesions with MRI fusion when indicated.
Learn more about Transperineal Prostate Biopsy Here.
Frequently Asked Questions and Answers
What is DNA?
DNA is the unique code that holds the instructions for your body’s functions. Based on your personal and family history of cancer, you may benefit from genetic testing that studies your DNA using a saliva or blood sample. Testing looks for gene changes (variants) that are linked to certain diseases or cancer types.
What are the benefits of genetic testing?
There are numerous advantages of finding out if one has a genetic mutation linked to prostate cancer to include:
- Making informed health choices, including options to prevent cancer
- Detecting cancer at an earlier and more treatable stage
- Assessing your risk of future cancers
- May prompt genetic testing of other family members and if they test positive, they may wish to undergo prostate cancer screening starting at an earlier age than men with no family history.
What is PSA and how is it connected to prostate cancer?
Prostate-specific antigen (PSA) is a protein produced within the prostate gland. PSA is mostly found in semen, but small amounts can also be found in the blood of healthy men. PSA levels naturally increase as men age because the prostate naturally enlarges over time. There are many reasons why PSA levels fluctuate, and higher levels may indicate the presence of prostate cancer or other prostate conditions (i.e. enlargement and inflammation).
Our Centre
We offer a central location north of Toronto, conveniently located near Hwy 7 and Hwy 404 in Richmond Hill, Ontario.
Treatments and consultations are performed on an outpatient basis in a new private, modern clinic setting with easy-to-access free underground/ surface parking with direct access by VIVA public transit or car. We are adjacent to hotel facilities (Sheraton Parkway Toronto, Courtyard and Residence Inn by Marriott, and Hilton Garden Inn) for our out-of-town patients and their families.
Our center is also fully accessible to individuals with disabilities.
Address
- 550 Hwy 7 Unit 317, Richmond Hill, ON L4B 3Z4
Hours
- Mon-Fri 9:00AM - 5:00PM
English (Canada) 
简体中文 